FDANews
FDAnews Device Daily Bulletin

Ovarian Cancer Screens Unreliable, FDA Says

Sept. 14, 2016

The FDA is alerting women about the risks associated with diagnostic tests for ovarian cancer.

The agency said it is especially concerned that women who show no symptoms could still be at risk for ovarian cancer but might delay effective preventive treatments.

“Despite extensive research and published studies, there are currently no screening tests for ovarian cancer that are sensitive enough to reliably screen for ovarian cancer without a high number of inaccurate results,” the safety notice said. Despite the lack of reliable tests, numerous companies market tests that claim to screen for and detect ovarian cancer. — Tamra Sami

View today's stories